Bio Farma: Sinovac’s Indonesian partner sets sights on making Chinese vaccines for Southeast Asia

Indonesia’s ambitious vaccination drive to inoculate two thirds of its population of 270 million began on Wednesday when President Joko Widodo received a shot of Sinovac Biotech’s CoronaVac vaccine.Southeast Asia’s largest economy intends to vaccinate its entire working population over the next 15 months, in a desperate bid to stem a pandemic that has infected some 869,000 people and killed 25,000.Its success will rely partly on Bio Farma, a 130-year-old state-owned vaccine manufacturer.As…

Read the original article at South China Morning Post